The Case for the Use of "Red Lines" in the Governance of Life Sciences Research | David Relman

About the Event: The nature of evolving risks in life sciences research, a brief history of risk governance, and the case for the use of so-called “red lines” in the governance of life sciences research will be presented. The goals of this presentation are to elicit discussion about the benefits and pitfalls of red lines, or guardrails, in general, including a historical perspective, and options for public policy recommendations to address concerns about the present and future risks arising from life sciences research.

About the Speaker: David A. Relman is the Thomas C. and Joan M. Merigan Professor in Medicine, and a Professor of Microbiology & Immunology at Stanford University, and Chief of Infectious Diseases at the Veterans Affairs Palo Alto Health Care System. He is also Senior Fellow at the Center for International Security and Cooperation at Stanford, and served as the Center’s Science Co-Director from 2013-2017. Relman was an early pioneer in the identification of previously-unrecognized microbial pathogens and in the modern study of the human microbiome. He served as President of the Infectious Diseases Society of America, and currently serves on the Defense Science Board at the Department of Defense and the Science and Security Board of the Bulletin of the Atomic Scientists. He is a member of the National Academy of Medicine and the American Academy of Arts & Sciences.

 All CISAC events are scheduled using the Pacific Time Zone.